The search for novel analgesics: targets and mechanisms.

Abstract

The management of the pain state is of great therapeutic relevance to virtually every medical specialty. Failure to manage its expression has deleterious consequence to the well-being of the organism. An understanding of the complex biology of the mechanisms underlying the processing of nociceptive information provides an important pathway towards development of novel and robust therapeutics. Importantly, preclinical models have been of considerable use in determining the linkage between mechanism and the associated behaviorally defined pain state. This review seeks to provide an overview of current thinking targeting pain biology, the use of preclinical models and the development of novel pain therapeutics. Issues pertinent to the strengths and weaknesses of current development strategies for analgesics are considered.

• Authors: Tony L Yaksh, Sarah A Woller, Roshni Ramachandran, Linda S Sorkin
• Journal: F1000prime reports (F1000Prime Rep) Vol. 7 Pg. 56 ( 2015) ISSN: 2051-7599 [Print] England
• PMID: 26097729 (Publication Type: Journal Article, Review)